A study in July 2024 by researchers at Mass Eye and Ear in Boston found that people taking semaglutide for type 2 diabetes or weight loss had a higher risk of developing nonarteritic anterior ischemic optic neuropathy, an eye condition that can cause blindness, than people taking medications other than GLP-1 drugs for diabetes or obesity
Helps reduce appetite Many people notice that meals feel easier to manage and cravings feel less intense, which can support a more consistent daily routine
Starts, maintenance, missed doses, and formulation switches are mapped
We'll verify your insurance simultaneously
Diarrhea may come and go throughout treatment, while headaches and abdominal discomfort typically lessen over time
Sperm viability, apoptosis, and intracellular reactive oxygen species levels in human spermatozoa before and after induction of oxidative stress